What pushed BIT.AX stock down 25% today?

BIT.AX stock dropped **25.00%** mainly due to thin liquidity and no fresh clinical news. Volume was **263,704**, well below the average of **4,629,329**, which magnified selling pressure. Expect direction to hinge on the Feb 26, 2026 earnings and any clinical updates.

What are the key financial metrics for BIT.AX stock?

Key metrics: price **A$0.003**, EPS **-0.01**, PE **-0.30**, PB **5.96**, market cap **A$4,981,740.00**, current ratio **2.23**. These show negative earnings and limited market value versus book and sales.

What is Meyka AI's short‑term forecast for BIT.AX stock?

Meyka AI's forecast model projects a base case of **A$0.005** within 12 months, implying **+66.67%** from **A$0.003**. Forecasts are model projections and not guarantees. Monitor trial news and the 26 Feb 2026 earnings update.

Should investors buy BIT.AX stock now?

BIT.AX stock suits speculative investors who accept trial and dilution risk. Holders should watch cash runway and upcoming trial readouts. Institutional investors may wait for clearer data or a partnership announcement before adding exposure.

AU Stocks

BIT.AX down 25% to A$0.003 on ASX: monitor Feb earnings for direction

ByDanny Kontos January 21, 2026January 21, 2026

BIT.AX stock fell 25.00% to A$0.003 at the ASX close on 21 Jan 2026, driven by thin liquidity and no fresh clinical news. Volume was 263,704 versus an average of 4,629,329, amplifying the move. Investors should watch the company update and the next earnings date on 26 Feb 2026 for a clearer direction.